Antileishmanial activity of quinazoline derivatives: Synthesis, docking screens, molecular dynamic simulations and electrochemical studies
- 1 March 2015
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 92, 314-331
Abstract
No abstract availableKeywords
Funding Information
- PAPIIT-UNAM (IN213914)
- CONACyT (6248)
This publication has 32 references indexed in Scilit:
- Target-based vs. phenotypic screenings in Leishmania drug discovery: A marriage of convenience or a dialogue of the deaf?International Journal for Parasitology: Drugs and Drug Resistance, 2014
- Drug repurposing and human parasitic protozoan diseasesInternational Journal for Parasitology: Drugs and Drug Resistance, 2014
- Antileishmanial phytochemical phenolics: Molecular docking to potential protein targetsJournal of Molecular Graphics and Modelling, 2014
- Miltefosine resistance in Leishmania donovani involves suppression of oxidative stress-induced programmed cell deathExperimental Parasitology, 2013
- Leishmaniasis: Current status of available drugs and new potential drug targetsAsian Pacific Journal of Tropical Medicine, 2012
- Antimalarial evaluation and docking studies of hybrid phenylthiazolyl-1,3,5-triazine derivatives: A novel and potential antifolate lead for Pf-DHFR-TS inhibitionExperimental Parasitology, 2012
- Recent advances in leishmaniasis treatmentInternational Journal of Infectious Diseases, 2011
- Dissecting the Metabolic Roles of Pteridine Reductase 1 in Trypanosoma brucei and Leishmania majorJournal of Biological Chemistry, 2011
- DNA and RNA Synthesis: AntifolatesChemical Reviews, 2005
- The Roles of Pteridine Reductase 1 and Dihydrofolate Reductase-Thymidylate Synthase in Pteridine Metabolism in the Protozoan Parasite Leishmania majorJournal of Biological Chemistry, 1997